Glen Harbor Capital Management’s West Pharmaceutical WST Stock Holding History

Glen Harbor Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.13M	Hold	14,994	–	–	0.04%	316
2019 Q2	$1.88M	Hold	14,994	–	–	0.04%	348
2019 Q1	$1.65M	Hold	14,994	–	–	0.04%	350
2018 Q4	$1.47M	Buy	14,994 +442	+3%	+$48K	0.04%	347
2018 Q3	$1.8M	Buy	14,552 +2,720	+23%	+$305K	0.04%	354
2018 Q2	$1.18M	Hold	11,832	–	–	0.03%	399
2018 Q1	$1.04M	Hold	11,832	–	–	0.02%	406
2017 Q4	$1.17M	Buy	11,832 +1,836	+18%	+$180K	0.03%	399
2017 Q3	$962K	Buy	9,996 +1,394	+16%	+$126K	0.02%	416
2017 Q2	$813K	Buy	8,602 +3,366	+64%	+$310K	0.02%	470
2017 Q1	$427K	Buy	5,236 +782	+18%	+$65.4K	0.01%	595
2016 Q4	$378K	Buy	+4,454	New	+$350K	0.01%	573

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Glen Harbor Capital Management's WST Position: Q3 2019 in Review

Glen Harbor Capital Management held its West Pharmaceutical (WST) position steady in Q3 2019 at 14,994 shares worth $2.13M. The position accounts for 0.04% of the portfolio, ranked #316.

Glen Harbor Capital Management first reported a position in WST in Q4 2016 and has held it in 12 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

Glen Harbor Capital Management held 14,994 shares of West Pharmaceutical worth $2.13M as of Q3 2019.
Glen Harbor Capital Management left its West Pharmaceutical share count unchanged in Q3 2019.
West Pharmaceutical made up 0.04% of Glen Harbor Capital Management's portfolio in Q3 2019, its #316 holding.
Glen Harbor Capital Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 12 quarters since.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.